삼성서울병원

Ko En

Kim, Mi Jin M.D

Expertise
crohn's disease, ulcerative colitis, liver disease, nutrition, pediatric endoscopy
Treament Schedule 05 月
DATE
THU
01
FRI
02
SAT
03
SUN
04
MON
05
TUE
06
WEB
07
THU
08
FRI
09
SAT
10
SUN
11
MON
12
TUE
13
WEB
14
THU
15
FRI
16
SAT
17
SUN
18
MON
19
TUE
20
WEB
21
THU
22
FRI
23
SAT
24
SUN
25
MON
26
TUE
27
WEB
28
THU
29
FRI
30
SAT
31
AM
PM
Treament Schedule 06 月
DATE
SUN
01
MON
02
TUE
03
WEB
04
THU
05
FRI
06
SAT
07
SUN
08
MON
09
TUE
10
WEB
11
THU
12
FRI
13
SAT
14
SUN
15
MON
16
TUE
17
WEB
18
THU
19
FRI
20
SAT
21
SUN
22
MON
23
TUE
24
WEB
25
THU
26
FRI
27
SAT
28
SUN
29
MON
30
AM
PM

Medical Education

2007~2012 Ph.D. in Medicine Chungnam National University, Korea
2004~2007 Master of Science Chungnam National University, Korea
1997~2003 College of Medicine, Chungnam National University, Korea

Post-Graduate Training

Fellowship   2009~2012 Division of Pediatric Gastroenterology, Samsung Medical Center, Korea
Residency   2005~2009 Department of Pediatrics, Chungnam National University Hospital, Korea
Internship   2003~2004 Chungnam National University Hospital, Korea

Professional Appointments

2018~Present Associate Professor Division of Pediatric Gastroenterology, Samsung Medical Center
2017~2018 Assistant Professor Department of Pediatrics, Chungnam National University Hospital
2013~2017 Assistant Professor Department of Pediatrics, Inje University Ilsanpaik Hospital

Professional Memberships

2009~Present Member Korean Association for the Study of Intestinal Diseases
2009~Present Member The Korean Society of Gastrointestinal Endoscopy
2009~Present Member The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition
2009~Present Member ?The Korean Pediatric Society
2009~Present Member ?The Korean College of?Helicobacter?and Upper Gastrointestinal Research

Selected Publications

  • FRONT PEDIATR 2024 10.3389/fped.2024.1479619 Risk factors affecting relapse after discontinuation of biologics in children with Crohn's disease who maintained deep remission Kim, H; Kim, YZ; Kim, SY; Choe, YH; Kim, MJ
    View PubMed
  • THER DRUG MONIT 2024 10.1097/FTD.0000000000001176 Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation Kim, ES; Chon, H; Kwon, Y; Lee, M; Kim, MJ; Choe, YH
    View PubMed
  • FRONT PEDIATR 2024 10.3389/fped.2023.1242009 Long-term outcomes of liver transplantation for biliary atresia and results of policy changes: over 20 years of follow-up experience Kwon, Y; Ahn, YJ; Yang, JH; Kim, ES; Choe, YH; Lee, SH; Kim, MJ
    View PubMed
  • J KOREAN MED SCI 2023 10.3346/jkms.2023.38.e401 A Report on a Nationwide Surveillance System for Pediatric Acute Hepatitis of Unknown Etiology in Korea Lee, KJ; Ko, JS; Park, KY; Kang, KS; Lee, KS; Hong, JA; Kim, SC; Lee, Y; Kang, B; Kim, YB; Kim, HJ; Eun, BW; Cho, HK; Kim, YJ; Kim, MJ; Lee, J; Lee, TJ; Oh, SH; Park, S; Ha Hwang, E; Sohn, S; Lim, JG; Kim, Y; Lee, YJ
    View PubMed
  • BIOMEDICINES 2023 10.3390/biomedicines11092575 Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn's Disease: A Pilot Study Kim, YZ; Kang, B; Kim, ES; Kwon, Y; Choe, YH; Kim, MJ
    View PubMed
  • FRONT MED-LAUSANNE 2023 10.3389/fmed.2023.1231066 Impact of the histologic grade of acute gastrointestinal graft-versus-host disease on outcomes in pediatric patients treated with allogeneic hematopoietic stem cell transplantation Kim, ES; Kwon, Y; Choe, YH; Kim, MJ; Yoo, KH
    View PubMed
  • THER ADV GASTROENTER 2023 10.1177/17562848231170948 Free antibodies-to-infliximab are biomarker for predicting the effect of dose intensification in pediatric Crohn's disease patients with secondary loss of response Kim, ES; Kwon, Y; Choe, YH; Kim, MJ
    View PubMed
  • ANN DERMATOL 2023 10.5021/ad.21.060 Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum Lee, HC; Kwon, Y; Kim, ES; Ahn, S; Choe, YH; Kim, MJ
    View PubMed
  • J KOREAN MED SCI 2023 10.3346/jkms.2023.38.e71 The Changes in Respiratory and Enteric Adenovirus Epidemiology in Korea From 2017 to June 2022 Kim, KR; Won, J; Kim, H; Kim, BI; Kim, MJ; Kim, JY; Gwack, J; Kim, YJ
    View PubMed
  • FRONT IMMUNOL 2022 10.3389/fimmu.2022.996875 Increased monocyte abundance as a marker for relapse after discontinuation of biologics in inflammatory bowel disease with deep remission Kwon, Y; Kim, YZ; Choe, YH; Kim, MJ
    View PubMed
  • BIOMEDICINES 2022 10.3390/biomedicines10102372 Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn's Disease Kwon, Y; Kim, ES; Kim, YZ; Choe, YH; Kim, MJ
    View PubMed
  • J KOREAN MED SCI 2022 10.3346/jkms.2022.37.e282 Vedolizumab Is Safe and Efficacious for the Treatment of Pediatric-Onset Inflammatory Bowel Disease Patients Who Fail a Primary Biologic Agent Choi, S; Kim, ES; Kwon, Y; Kim, MJ; Choe, YH; Choe, BH; Kang, B
    View PubMed
  • GUT LIVER 2022 10.5009/gnl210488 Comparison between Pediatric Crohn's Disease and Ulcerative Colitis at Diagnosis in Korea: Results from a Multicenter, Registry-Based, Inception Cohort Study Park, S; Kang, B; Kim, S; Choi, S; Suh, HR; Kim, ES; Park, JH; Kim, MJ; Choe, YH; Lee, YJ; Park, JH; Ryoo, E; Koh, H; Choe, BH
    View PubMed
  • THER DRUG MONIT 2022 10.1097/FTD.0000000000000976 Comparison of Ustekinumab Trough Concentrations Measured by 2 ELISA Kits and Evaluation of Clinical Response in Crohn's Disease Kwon, Y; Kang, B; Kim, ES; Choe, YH; Kim, MJ
    View PubMed
  • WORLD J GASTROENTERO 2022 10.3748/wjg.v28.i28.3666 How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study Kwon, Y; Kim, ES; Choe, YH; Kim, MJ
    View PubMed
  • FRONT PEDIATR 2022 10.3389/fped.2022.853019 Increased Demand for Therapeutic Drugs in Pediatric Ulcerative Colitis Patients With Extraintestinal Manifestations Kwon, Y; Kim, ES; Choe, YH; Kim, MJ
    View PubMed
  • FRONT PEDIATR 2022 10.3389/fped.2022.846273 Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children Kwon, Y; Kim, ES; Choe, YH; Kim, MJ
    View PubMed
  • SCI REP-UK 2022 10.1038/s41598-021-04304-6 Discontinuation of Azathioprine could be considered in pediatric patients with Crohn's disease who have sustained clinical and deep remission Jeong, TJ; Kim, ES; Kwon, Y; Kim, S; Seo, SW; Choe, YH; Kim, MJ
    View PubMed
  • ALIMENT PHARM THER 2022 10.1111/apt.16769 NUDT15 intermediate metabolisers are associated with lower loss of response in paediatric Crohn's disease patients treated by combination treatment with infliximab and azathioprine Kim, ES; Choi, S; Choi, SY; Park, JH; Choe, BH; Lee, SY; Kim, MJ; Choe, YH; Kang, B
    View PubMed
  • GUT LIVER 2021 10.5009/gnl20212 Anti-Saccharomyces cerevisiae Antibody in Pediatric Crohn's Disease Patients without Mucosal Healing Is a Useful Marker of Mucosal Damage Kim, MJ; Kim, E; Kang, B; Lee, Y; Kang, ES; Choe, YH
    View PubMed
  • FRONT IMMUNOL 2021 10.3389/fimmu.2021.698721 Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity Kim, ES; Kim, D; Yoon, Y; Kwon, Y; Park, S; Kim, J; Ahn, KM; Ahn, S; Choe, YH; Kim, YJ; Kim, MJ
    View PubMed
  • YONSEI MED J 2021 10.3349/ymj.2021.62.7.608 Infliximab Therapy for Children with Moderate to Severe Ulcerative Colitis: A Step-Up versus a Top-Down Strategy Kim, MJ; Kim, E; Kang, B; Choe, YH
    View PubMed
  • J PEDIATR GASTR NUTR 2021 10.1097/MPG.0000000000003070 Therapeutic Drug Monitoring of Adalimumab During Long-term Follow-up in Paediatric Patients With Crohn Disease Kim1, MJ; Kim, E; Kang, B; Choe, YH
    View PubMed
  • YONSEI MED J 2021 10.3349/ymj.2021.62.5.470 Therapeutic Lymphatic Embolization in Pediatric Primary Intestinal Lymphangiectasia Kwon1, Y; Kim, ES; Choe, YH; Hyun, D; Kim, MJ
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-84766-w COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity Kim1, ES; Kwon, Y; Choe, YH; Kim, MJ
    View PubMed
  • BMC PEDIATR 2021 10.1186/s12887-020-02447-5 Individual approach for treatment of primary intestinal lymphangiectasia in children: single-center experience and review of the literature Kwon1, Y; Kim, ES; Choe, YH; Kim, MJ
    View PubMed
  • PHARMACOGEN PERS MED 2020 10.2147/PGPM.S279446 The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn's Disease Ha1, C; Kim, ES; Kwon, Y; Choe, YH; Kim, MJ; Lee, SY
    View PubMed
  • SCI REP-UK 2020 10.1038/s41598-020-75938-1 Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn's disease than in European patients Kim1, ES; Kwon, Y; Choe, YH; Kim, MJ
    View PubMed
  • FRONT MICROBIOL 2020 10.3389/fmicb.2020.02099 Delayed Establishment of Gut Microbiota in Infants Delivered by Cesarean Section Kim1, G; Bae, J; Kim, MJ; Kwon, H; Park, G; Kim, SJ; Choe, YH; Kim, J; Park, SH; Choe, BH; Shin, H; Kang, B
    View PubMed
  • INDIAN PEDIATR 2019 10.1007/s13312-019-1649-5 Correlation of Dickkopf-1 with Inflammation in Crohn Disease Kim1, MJ; Choe, YH
    View PubMed